YYAI:NASDAQAiRWA Inc. Analysis
Data as of 2026-05-12 - not real-time
$0.69
Latest Price
8/10Risk
Risk Level: High
Executive Summary
AiRWA Inc. (YYAI) is trading well below its 20‑day (≈$0.81) and 50‑day (≈$0.89) moving averages, with the price hovering near the identified support of $0.66 and a bearish MACD histogram. The RSI around 36 hints at slight oversold conditions, yet the 30‑day volatility exceeds 85% and a beta of roughly 2.8 signal extreme price swings. Volume is on the rise, but the market cap of only $29 M underscores the thin‑float nature of the stock.
Fundamentally, the company posts modest revenue growth (≈13%) and a healthy cash pile of $41 M against minimal debt, but operating margins are negative and ROE is near zero. Valuation multiples are starkly low – a trailing PE of 0.12, price‑to‑book of 0.16, and a DCF‑derived fair value near $5.8 – suggesting deep discounting. Recent insider buying at $0.91 per share and shareholder approval of a reverse split and incentive plan add a speculative catalyst, while the lack of dividend and the high‑risk tech‑infrastructure sector keep the outlook cautious.
Fundamentally, the company posts modest revenue growth (≈13%) and a healthy cash pile of $41 M against minimal debt, but operating margins are negative and ROE is near zero. Valuation multiples are starkly low – a trailing PE of 0.12, price‑to‑book of 0.16, and a DCF‑derived fair value near $5.8 – suggesting deep discounting. Recent insider buying at $0.91 per share and shareholder approval of a reverse split and incentive plan add a speculative catalyst, while the lack of dividend and the high‑risk tech‑infrastructure sector keep the outlook cautious.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below key moving averages and support level
- Bearish MACD and negative histogram
- Extreme short‑term volatility and high beta
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Deep discount to DCF fair value
- Strong cash position versus minimal debt
- Ongoing operating losses and modest profit margins
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Potential upside from reverse split and incentive plan
- Low price‑to‑book and price‑to‑sales ratios
- Growth opportunity in AI‑driven matchmaking across multiple regions
Key Metrics & Analysis
Financial Health
Revenue Growth113.10%
Profit Margin-3.54%
P/E Ratio0.1
ROE0.01%
ROA0.68%
Debt/Equity0.42
P/B Ratio0.2
Op. Cash Flow$3.4M
Free Cash Flow$5.5M
Industry P/E39.0
Technical Analysis
TrendBearish
RSI36.6
Support$0.66
Resistance$1.00
MA 20$0.81
MA 50$0.89
MA 200$40.97
MACDBearish
VolumeIncreasing
Fear & Greed Index87.91
Valuation
Fair Value$5.77
GradeUndervalued
TypeValue
Risk Assessment
Beta2.82
Volatility85.46%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.